Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participantsThe Lancet (British edition), 2021-09, Vol.398 (10304), p.957-980 [Peer Reviewed Journal]2021 World Health Organization ;Copyright © 2021 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;info:eu-repo/semantics/openAccess ;Attribution ;2021 World Health Organization 2021 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01330-1 ;PMID: 34450083Full text available |
|
2 |
Material Type: Article
|
Portopulmonary hypertension and hepatopulmonary syndromeThe Lancet (British edition), 2004-05, Vol.363 (9419), p.1461-1468 [Peer Reviewed Journal]2004 Elsevier Ltd ;2004 INIST-CNRS ;Copyright Lancet Ltd. May 1, 2004 ;Copyright Elsevier Limited May 1, 2004 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(04)16107-2 ;PMID: 15121411 ;CODEN: LANCAOFull text available |
|
3 |
Material Type: Article
|
Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studiesThe Lancet (British edition), 2016-07, Vol.388 (10043), p.465-475 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2016 Elsevier B.V. ;Copyright Elsevier Limited Jul 30, 2016 ;2016. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)30467-6 ;PMID: 27216139 ;CODEN: LANCAOFull text available |
|
4 |
Material Type: Article
|
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trialThe Lancet (British edition), 2010-12, Vol.376 (9756), p.1903-1909 [Peer Reviewed Journal]Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 4-Dec 10, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)62039-9 ;PMID: 21093036 ;CODEN: LANCAOFull text available |
|
5 |
Material Type: Article
|
A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertensionThe Lancet (British edition), 2016-11, Vol.388 (10060), p.2665-2712 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright Elsevier Limited Nov 26, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31134-5 ;PMID: 27671667 ;CODEN: LANCAOFull text available |
|
6 |
Material Type: Article
|
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 studyThe Lancet (British edition), 2014-02, Vol.383 (9917), p.622-629 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 15, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)62192-3 ;PMID: 24210779 ;CODEN: LANCAOFull text available |
|
7 |
Material Type: Article
|
A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trialThe Lancet (British edition), 2019-10, Vol.394 (10205), p.1231-1242 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31949-X ;PMID: 31488369Full text available |
|
8 |
Material Type: Article
|
Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trialThe Lancet (British edition), 2010-07, Vol.376 (9736), p.163-172 [Peer Reviewed Journal]Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 17-Jul 23, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60964-6 ;PMID: 20619448 ;CODEN: LANCAOFull text available |
|
9 |
Material Type: Article
|
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialThe Lancet (British edition), 2020-05, Vol.395 (10234), p.1444-1451 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30554-7 ;PMID: 32234534Full text available |
|
10 |
Material Type: Article
|
Hypertension in developing countriesThe Lancet (British edition), 2012-08, Vol.380 (9841), p.611-619 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60861-7 ;PMID: 22883510 ;CODEN: LANCAOFull text available |
|
11 |
Material Type: Article
|
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet (British edition), 2019-04, Vol.393 (10181), p.1597-1608 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31875-0 ;PMID: 30910320Full text available |
|
12 |
Material Type: Article
|
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trialThe Lancet (British edition), 2017-11, Vol.390 (10108), p.2160-2170 [Peer Reviewed Journal]2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Nov 11, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32281-X ;PMID: 28859944Full text available |
|
13 |
Material Type: Article
|
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertensionThe Lancet (British edition), 2010-03, Vol.375 (9718), p.895-905 [Peer Reviewed Journal]Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 13-Mar 19, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60308-X ;PMID: 20226988 ;CODEN: LANCAOFull text available |
|
14 |
Material Type: Article
|
The double challenge of resistant hypertension and chronic kidney diseaseThe Lancet (British edition), 2015-10, Vol.386 (10003), p.1588-1598 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 17, 2015 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)00418-3 ;PMID: 26530623 ;CODEN: LANCAOFull text available |
|
15 |
Material Type: Article
|
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trialThe Lancet (British edition), 2009-10, Vol.374 (9699), p.1423-1431 [Peer Reviewed Journal]Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Oct 24-Oct 30, 2009 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61500-2 ;PMID: 19748665 ;CODEN: LANCAOFull text available |
|
16 |
Material Type: Article
|
Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trialThe Lancet (British edition), 2015-06, Vol.385 (9986), p.2492-2501 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 20, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61998-X ;PMID: 25817374 ;CODEN: LANCAOFull text available |
|
17 |
Material Type: Article
|
Diabetes and hypertension: the bad companionsThe Lancet (British edition), 2012-08, Vol.380 (9841), p.601-610 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60987-8 ;PMID: 22883509 ;CODEN: LANCAOFull text available |
|
18 |
Material Type: Article
|
Clinical features of paediatric pulmonary hypertension: a registry studyThe Lancet (British edition), 2012-02, Vol.379 (9815), p.537-546 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 11-Feb 17, 2012 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61621-8 ;PMID: 22240409 ;CODEN: LANCAOFull text available |
|
19 |
Material Type: Article
|
Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertensionThe Lancet (British edition), 2010-03, Vol.375 (9718), p.938-948 [Peer Reviewed Journal]Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 13-Mar 19, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60309-1 ;PMID: 20226991 ;CODEN: LANCAOFull text available |
|
20 |
Material Type: Article
|
Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trialThe Lancet (British edition), 2019-05, Vol.393 (10183), p.1807-1818 [Peer Reviewed Journal]2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2019. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)33212-4 ;PMID: 30948284Full text available |